Bexson Biomedical

Developer of ketamine therapies for chronic and acute pain disorders

placeSanta Barbara, California, United States calendar_todayFounded 2017 groups6 employees language bexsonbiomedical.com

Registered entities

Innovation

10 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 528 times.

YearFilings
20191
20202
20213
20225
20235
20244
20256
20261

Investor mix

7 investors on record; lead investors include Noetic Psychedelic Fund.

Investor typeCountShare
Venture capital7100%
Coming soon